Caldwell Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$904 Buy
151
+20
+15% +$150 ﹤0.01% 773
2025
Q4
$939 Hold
131
﹤0.01% 744
2025
Q3
$1.4K Sell
131
-73
-36% -$716 ﹤0.01% 730
2025
Q2
$1.98K Hold
204
﹤0.01% 718
2025
Q1
$3.04K Buy
204
+125
+158% +$1.92K ﹤0.01% 714
2024
Q4
$1.18K Sell
79
-15
-16% -$244 ﹤0.01% 692
2024
Q3
$1.8K Sell
94
-36
-28% -$746 ﹤0.01% 679
2024
Q2
$2.69K Buy
130
+67
+106% +$1.33K ﹤0.01% 668
2024
Q1
$1.18K Sell
63
-9
-13% -$154 ﹤0.01% 692
2023
Q4
$1.04K Sell
72
-25
-26% -$340 ﹤0.01% 694
2023
Q3
$1.68K Hold
97
﹤0.01% 687
2023
Q2
$2.02K Sell
97
-57
-37% -$1.24K ﹤0.01% 720
2023
Q1
$3.62K Sell
154
-29
-16% -$779 ﹤0.01% 681
2022
Q4
$5.11K Sell
183
-19
-9% -$486 ﹤0.01% 656
2022
Q3
$4.73K Sell
202
-431
-68% -$13K ﹤0.01% 659
2022
Q2
$21.4K Sell
633
-63
-9% -$2.21K ﹤0.01% 538
2022
Q1
$24.3K Sell
696
-50
-7% -$1.71K ﹤0.01% 544
2021
Q4
$22.7K Sell
746
-306
-29% -$9.97K ﹤0.01% 546
2021
Q3
$34.5K Sell
1,052
-2,071
-66% -$66.3K ﹤0.01% 497
2021
Q2
$94.5K Buy
+3,123
New +$103K 0.01% 374

Other funds holding OGN

Caldwell Trust's OGN Position: Q1 2026 in Review

Caldwell Trust increased its Organon & Co (OGN) stake by 15% in Q1 2026, buying an estimated $150 and bringing the position to 151 shares worth $904. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Caldwell Trust first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $94.5K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Caldwell Trust held 151 shares of Organon & Co worth $904 as of Q1 2026.
  • Caldwell Trust bought 20 Organon & Co shares in Q1 2026, an estimated $150.
  • Organon & Co made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #773 holding.
  • Caldwell Trust first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Caldwell Trust's Organon & Co position peaked at $94.5K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.